Thrombus pharmacotherapy
Antithrombotic therapy plays a fundamental role in the treatment of arterial and venous thrombotic diseases and in percutaneous coronary intervention. The landscape of anticoagulant therapy for atrial fibrillation has changed significantly with the availability of targeted new oral anticoagulants that are safer than warfarin. Antiplatelet therapy is essential to the treatment of acute coronary syndrome and for preventing ischemic complications of percutaneous coronary intervention. The availability of parenteral anticoagulants and antiplatelet agents increases the armamentarium for improving outcomes in patients with acute ischemic heart disease. This chapter reviews the available options for oral and parenteral anticoagulant and antiplatelet therapies.
